Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
Bergallo C, Jasovich A, Teglia O, Oliva ME, Lentnek A, de Wouters L, Zlocowski JC, Dukart G, Cooper A, Mallick R; 308 Study Group. Bergallo C, et al. Among authors: jasovich a. Diagn Microbiol Infect Dis. 2009 Jan;63(1):52-61. doi: 10.1016/j.diagmicrobio.2008.09.001. Epub 2008 Nov 5. Diagn Microbiol Infect Dis. 2009. PMID: 18990531 Clinical Trial.
Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.
Tanaseanu C, Bergallo C, Teglia O, Jasovich A, Oliva ME, Dukart G, Dartois N, Cooper CA, Gandjini H, Mallick R; 308 Study Group; 313 Study Group. Tanaseanu C, et al. Among authors: jasovich a. Diagn Microbiol Infect Dis. 2008 Jul;61(3):329-38. doi: 10.1016/j.diagmicrobio.2008.04.009. Epub 2008 May 27. Diagn Microbiol Infect Dis. 2008. PMID: 18508226 Clinical Trial.
Efficacy of amoxicillin-sulbactam, given twice-a-day, for the treatment of community-acquired pneumonia: a clinical trial based on a pharmacodynamic model.
Jasovich A, Soutric J, Morera G, Mastruzzo M, Vesco E, Izaguirre M, Mobilia L, Prieto S, Franco D, Curcio D, Absi R, Larrateguy L, Bustos JL, Oliva ME, Arenoso H, Bantar C. Jasovich A, et al. J Chemother. 2002 Dec;14(6):591-6. doi: 10.1179/joc.2002.14.6.591. J Chemother. 2002. PMID: 12583551 Clinical Trial.
[Updated acute community-acquired pneumonia in adults: Guidelines for initial antimicrobial therapy based on local evidence from the South American Working Group (ConsenSur II)].
Bantar C, Curcio D, Jasovich A, Bagnulo H, Arango A, Bavestrello L, Famiglietti A, García P, Lopardo G, Losanovscky M, Martínez E, Pedreira W, Piñeyro L, Remolif C, Rossi F, Varón F. Bantar C, et al. Among authors: jasovich a. Rev Chilena Infectol. 2010 Jun;27 Suppl 1:S9-S38. Epub 2010 Jul 26. Rev Chilena Infectol. 2010. PMID: 20737129 Free article. Spanish.
Acute community-acquired pneumonia in adults: guidelines for initial antimicrobial therapy based on local evidence from a South American Working Group (ConsenSur).
Bantar C, Bavestrello L, Curcio D, Jasovich A, Absi R, Bagnulo H, Famiglietti A, García P, Labarca J, Mera J, Pedreira W, Sader H, Thompson L, Wey S; South American Working Group ConsenSur Group. Bantar C, et al. Among authors: jasovich a. J Chemother. 2002 Dec;14 Suppl 4:1-22. doi: 10.1080/1120009x.2002.11782352. J Chemother. 2002. PMID: 12680511
Rationale for treating community-acquired lower respiratory tract infections with amoxicillin/sulbactam combination through pharmacodynamic analysis in the setting of aminopenicillin-resistant organisms.
Bantar C, Nicola F, Fernandez Canigia L, Arenoso HJ, Soutric J, Montoto M, Blanco M, Smayevsky J, Jasovich A. Bantar C, et al. Among authors: jasovich a. J Chemother. 2001 Aug;13(4):402-6. doi: 10.1179/joc.2001.13.4.402. J Chemother. 2001. PMID: 11589483
27 results